MESOBLAST LIMITED

2.33%

$2.52

Market Cap $3.225B

Healthcare Biotechnology

Mesoblast Limited is an Australia-based company, which is engaged in developing... Mesoblast Limited is an Australia-based company, which is engaged in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. It has leveraged its proprietary mesenchymal lineage cell therapy technology platform to establish a broad portfolio of late-stage product candidates. It is developing product candidates for distinct indications based on its remestemcel-L and rexlemestrocel-L allogeneic stromal cell technology platforms. Remestemcel-L is being developed for inflammatory diseases in children and adults including steroid refractory acute graft versus host disease, and biologic-resistant inflammatory bowel disease. Rexlemestrocel-L is being developed for advanced chronic heart failure (REVASCOR) and chronic low back pain (MPC-06-ID). Two products have been commercialized in Japan and Europe by the Company's licensees. It has established commercial partnerships in Europe and China for certain Phase III assets.More

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care. LATEST: Race Oncology Accelerates Game-Changing Cancer Drug.

Latest Threads

Tag

Subject

MSB

Cell Therapy News/Articles

330 331 332

09:42

19K

8.3M

09:42

Last post fluffington

19K

8.3M

MSB

Ann: Quarterly Activities/Appendix 4C Cash Flow Report

4 5 6

08:12

338

137K

08:12

Last post The Yankee

338

137K

MSB

NASDAQ Meso daily flow charts

3 4 5

06:12

280

116K

06:12

Last post LearningEachDay

280

116K

MSB

Ann: Ceasing to be a substantial holder

25/07/25

3.1K

25/07/25

Last post stevo1963

3.1K

MSB

MSB Shorts

4 5 6

25/07/25

358

117K

25/07/25

Last post ssm73

358

117K

MSB Biotech

MSB - a new dawn

36 37 38

25/07/25

2.2K

951K

25/07/25

Last post pld89

2.2K

951K

MSB

Mesoblast 2025: The year of acting like a publicly listed company

21 22 23

25/07/25

1.3K

516K

25/07/25

Last post Pledge

1.3K

516K

MSB

Ann: Ceasing to be a substantial holder

25/07/25

3.4K

25/07/25

Last post stocksa

3.4K

See All Discussions

Timeline

Ceasing to be a substantial holder
25 Jul 18:50	Share

Ceasing to be a substantial holder
25 Jul 08:17	Share

Becoming a substantial holder
23 Jul 08:14	Share

Ceasing to be a substantial holder
21 Jul 08:21	Share

Quarterly Activities/Appendix 4C Cash Flow Report
18 Jul 09:58	Share

Becoming a substantial holder
18 Jul 08:20	Share

Notification of cessation of securities - MSB
14 Jul 18:23	Share

Notification regarding unquoted securities - MSB
14 Jul 18:19	Share

Application for quotation of securities - MSB
14 Jul 18:14	Share

Notification regarding unquoted securities - MSB
14 Jul 18:08	Share

Ceasing to be a substantial holder
08 Jul 18:46	Share

Becoming a substantial holder
07 Jul 08:20	Share

Mesoblast and FDA Align on Key Items for Revascor BLA
01 Jul 09:49	Share

Ceasing to be a substantial holder
26 Jun 08:21	Share

Ceasing to be a substantial holder
18 Jun 08:19	Share

Becoming a substantial holder
17 Jun 08:23	Share

Ceasing to be a substantial holder
16 Jun 08:19	Share

Mesoblast Maintains Momentum with FDA
12 Jun 10:14	Share

Becoming a substantial holder
06 Jun 08:21	Share

Becoming a substantial holder
05 Jun 08:18	Share

Becoming a substantial holder
03 Jun 15:59	Share

Ceasing to be a substantial holder
03 Jun 08:21	Share

FDA Provides Ryoncil 7 Years Orphan-Drug Exclusive Approval
15 May 10:01	Share

Becoming a substantial holder
14 May 08:18	Share

Ceasing to be a substantial holder
09 May 08:24	Share

Becoming a substantial holder
08 May 08:20	Share

Ceasing to be a substantial holder
07 May 15:26	Share

Becoming a substantial holder
02 May 14:07	Share

Quarterly Activities/Appendix 4C Cash Flow Report
30 Apr 10:13	Share

Initial Director's Interest Notice
29 Apr 09:37	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $2.52		Change -0.060(2.33%)		Mkt cap ! $3.225B

Open	High	Low	Value	Volume
$2.58	$2.61	$2.50	$12.63M	4.955M

Buyers (Bids)

No.	Vol.	Price($)
1	8366	$2.51

Sellers (Offers)

Price($)	Vol.	No.
$2.53	8780	4

View Market Depth

No.	Vol.	Price($)
1	8366	2.510
1	3577	2.500
1	1204	2.490
2	8430	2.470
1	22300	2.460

Price($)	Vol.	No.
2.530	1289	2
2.540	3800	1
2.550	20000	1
2.580	40000	1
2.590	18880	2

Last trade - 16.10pm 25/07/2025 (20 minute delay)

MSB (ASX) Chart

MESOBLAST LIMITED

Latest Threads

Timeline

Featured News

Latest Videos

Mesoblast (ASX:MSB) flags strengthened heart function in latest trial results

28 Feb 2023 10:07 (AEDT)

Latest Articles

The market shrugged at Mesoblast's latest FDA win. Is it just another Droneshield?

Mesoblast (ASX:MSB) has revealed the US FDA has given its flagship drug a 7 year exclusivity period, blocking...

Mesoblast dips on 'belief' it's not subject to US tariffs – despite Singaporean lab

Mesoblast (ASX:MSB) has seen shares fall just shy of -3% heading into lunchtime trades despite apparent tariff relief.

Mesoblast kicks off treatment for first 3 kids with graft-host disease. So why are shares down?

otCopper favourite Mesoblast (ASX:MSB) has announced it's begun treating the first 3 children with skin graft-versus-host disease in the US, at the same time the company received medicare (US) and medicaid coverage.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News